Compare Alcon AG (ALC) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Dolby Laboratories, Inc. — how do they compare? Alcon AG trades at $74.19 (market cap $36.44B), while Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B). The key difference: Alcon AG is far larger — about 6.3× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.35%). Which is the better fit depends on your goals.
| ALC | DLB | |
|---|---|---|
Market Cap | $36.44B | $5.75B |
Sector | Health | Industrials |
52-Week High | $90.12 | $75.62 |
52-Week Low | $62.02 | $48.51 |
Enterprise Value | $40.28B | $5.12B |
Dividend Yield | 0.48% | 2.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
